Securitas AB Interim Report Q3 2026 | January–September

For July–September 2026, sales were MSEK 38,566, essentially unchanged from MSEK 38,521 a year earlier; organic sales growth was 0%, while adjusted organic sales growth was 3%. Operating income before amortization rose to MSEK 3,161 from MSEK 3,107, and the operating margin edged up to 8.2% from 8.1%. Reported EPS increased to SEK 3.68 from SEK 1.09, while EPS before items affecting comparability declined to SEK 3.28 from SEK 3.34; operating cash flow was 82% versus 106%.

Analysis

The earnings quality is weaker than the headline EPS comparison implies: the prior-period IAC makes reported EPS look dramatically better, while EPS before IAC declined. Flat organic sales and a lower adjusted organic growth rate point to deceleration; a 10 bp decline in adjusted operating margin offers no evidence yet of operating leverage. Growth is concentrated in technology and solutions, which may be gaining mix at the expense of slower businesses, but the fragment does not identify the company or segment economics, so that read-through needs verification.

The cash-flow ratio fell to 82% from 106%. One quarter is not enough to infer structural deterioration, but working capital or cash-conversion weakness could matter more than the modest operating-income increase if it persists. Near term, the cleaner underlying EPS signal may outweigh the optically strong reported figure. Over 1–3 months, watch order intake, organic growth by segment, adjusted margin, and cash conversion; over 6–18 months, the key question is whether technology-led growth can offset stagnation elsewhere without eroding margins. The company identity, full January–September figures, valuation, and management outlook are missing; there is not enough basis for a directional single-name trade.

Key Decisions for Investors

• Do not trade the reported EPS jump in isolation; compare consensus and guidance with EPS before IAC and adjusted organic growth once the full report is available.
• Put the name on a watchlist rather than initiate a position until company identity, valuation, segment contribution, and the truncated January–September results are verified.
• Treat persistent cash conversion below 100% alongside slowing organic growth or further adjusted-margin decline as a bearish confirmation; improving conversion and renewed organic acceleration would falsify that concern.
• Avoid inferring a competitor or supplier winner from technology-and-solutions growth alone: verify whether it reflects durable demand, mix, acquisitions, or a change in reporting scope.